In addition, coumarins exhibit acetylcholinesterase (AChE) inhibitory activity, which in turn increases acetylcholine (ACh) levels in the brain [58–60], ultimately leading to decreases in cognitive impairment caused by Aβ1–42 injection. This evidence concerns the gene ACHE and Cognitive impairment.